News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Erenumab works well in chronic migraine patients across Asia
06 Dec 2022
byJairia Dela Cruz
Erenumab proves to be effective at lowering the number of monthly migraine days in Asian patients with chronic migraine while having a favourable safety profile, according to the results of DRAGON study.
06 Dec 2022

Weekly somapacitan on par with daily growth hormone in children
06 Dec 2022
byStephen Padilla
Weekly somapacitan is noninferior to daily growth hormone (GH) in terms of height velocity (HV), with comparable safety and mean insulin-like growth factor-1 standard deviation score (IGF-1 SDS) levels in treatment-naïve children with growth hormone deficiency (GHD), a study has shown.
06 Dec 2022






